Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

COVID 19: U.S. says that “Ultimate Game Changer” Vaccine is on the Way

Published 04/02/2020, 12:56 AM
Updated 04/02/2020, 01:00 AM

By Gina Lee

Investing.com - Australia announced a $973 million package for its childcare sector.

Japan’s government debated an economic package including ECMO machines.

The United States is “on target” to develop a COVID-19 vaccine with biotech company Moderna within 12 to 18 months.

As of April 1, the number of confirmed cases globally stood at 827,419 with 40,777 deaths, according to the World Health Organisation.

Australia

Prime Minister Scott Morrison announced an A$1.6 billion ($973 million) package for the country’s 13,000-strong childcare sector over the next three months.

The services will be rendered free of charge as they will be paid from taxpayer subsidies.

Japan

The government is mulling the increased production of extracorporeal membranous oxygenation (ECMO) machines as part of an economic package to combat COVID-19.

The machines will replace a person’s breathing to supply oxygen and remove carbon dioxide.

United States

White House health advisor Anthony Fauci announced overnight that the first human trial to test a potential COVID-19 vaccine is on target and will be an “ultimate game changer”.

Biotech company Moderna is working with Fauci and other health officials to develop the vaccine. Human trials started on March 16.

The vaccine is estimated to be distributed within 12 to 18 months, with phase two trials expected to begin in a “few months”. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.